Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Songxia Pharmaceutical is a Chinese pharmaceutical company based in Foshan, Guangdong Province, specializing in the development and manufacturing of over-the-counter (OTC) and prescription medications. Established in 1994, the company has built a diverse portfolio that includes chemical drugs, traditional Chinese medicines (TCM), and health supplements. Its flagship products are primarily focused on respiratory health, such as Compound Paracetamol and Amantadine Hydrochloride capsules used for treating the common cold and influenza. The company operates large-scale, GMP-certified manufacturing facilities capable of producing various dosage forms including capsules, tablets, and granules. Guangdong Songxia Pharmaceutical primarily serves the domestic Chinese market through an extensive distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Songxia Pharmaceutical.